Nearly four months after her first injection, a Ballard woman who became the first person to participate in a COVID-19 vaccine trial says she’s doing well.
The vaccine, developed by the National Institutes of Health and Moderna Inc., was administered to 45 people in Seattle in the first phase of its trial through the Kaiser Permanente Washington Health Research Institute.
Participants received two doses of the vaccine about a month apart, and are being monitored through regular blood tests for the next year.
Enterprise7
Article URL : https://mynorthwest.com/2001735/covid-19-vaccine-trial-recipient/